Erratum to: Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide study

The Letter to the Editor “Prevalence and mortality trends of hemoglobinopathies in Italy: a nationwide study” by Gianesin et al.¹ was published with an incorrect affiliation for the authors G. Graziadei and E. Cassinerio due to a revision error. The correct affiliations for the authors are reported below. We apologize to the authors and readers.

Barbara Gianesin,¹ Frédéric B. Piel,² Khaled M. Musallam,^3-5 Susanna Barella,⁶ Maddalena Casale,⁷ Elena Cassinerio,⁸ Rosario Di Maggio,⁹ Antonia Gigante,¹ Maria Rita Gamberini,¹⁰ Giovanna Graziadei,⁸ Roberto Lisi,¹¹ Filomena Longo,¹⁰ Aurelio Maggio,⁹ Raffaella Origa,¹² Annamaria Pasanisi,¹³ Silverio Perrotta,⁷ Antonio Giulio Piga,¹⁴ Valeria Maria Pinto,¹⁵ Rosamaria Rosso,¹⁶ Giacomo Robello,¹⁷ Giovanna Russo,¹⁸ Marco Zecca,¹⁹ Lucia De Franceschi,^20,21 and Gian Luca Forni;^1,22 Collaborative Groups: Italian Hemoglobinopathies National Survey Group National Survey Group

¹For Anemia Foundation ETS, Genoa, Italy; ²Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK; ³Center for Research on Rare Blood Disorders (CR-RBD), Burjeel Medical City, Abu Dhabi, United Arab Emirates; ⁴Department of Public Health & Epidemiology, Khalifa University, Abu Dhabi, United Arab Emirates; ⁵Division of Hematology/Oncology, Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA; ⁶SC Centro delle Microcitemie e Anemie Rare, ASL Cagliari, Cagliari, Italy; ⁷Department of Women, Child and General and Specialized Surgery, University Luigi Vanvitelli, Naples, Italy; ⁸SC Medicina ad Indirizzo Metabolico, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy; ⁹Campus of Haematology Franco and Piera Cutino, UOC Ematologia per le Malattie Rare Del Sangue e degli Organi Ematopoietici, AOOR Villa Sofia-V. Cervello, Palermo, Italy; ¹⁰SSD Day Hospital of Thalassemia and Hemoglobinopathies, Department of Specialized Medicine, Azienda Ospedaliero Universitaria S. Anna, Ferrara, Italy; ¹¹Thalassemia Unit, ARNAS Garibaldi, Catania, Italy; ¹²Università di Cagliari, SC Centro delle Microcitemie e Anemie Rare, ASL Cagliari, Cagliari, Italy; ¹³Centro della Microcitemia A. Quarta, Hematology Unit, A. Perrino Hospital, Brindisi, Italy; ¹⁴Department of Clinical and Biological Sciences, University of Turin, Turin, Italy; ¹⁵Hematology and Cellular Therapy, IRCCS Ospedale Policlinico San Martino, Genova, Italy; ¹⁶UOSD di Talassemia ed Emoglobinopatie, Azienda Ospedaliero Universitaria Policlinico San Marco, Catania, Italy; ¹⁷Centro della Microcitemia e Anemie Congenite e del Dismetabolismo del Ferro, Ospedale Galliera, Genoa, Italy; ¹⁸Pediatric Hematology/Oncology Unit, Università di Catania, Catania, Italy; ¹⁹Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; ²⁰Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy; ²¹Azienda Ospedaliera Universitaria Integrata, Verona, Italy and ²²Hematology Unit, IRCCS Giannina Gaslini, Genoa, Italy

Footnotes

• Received February 12, 2025
• Accepted February 12, 2025

Correspondence

G.L. Forni gianlucaforni14@gmail.com